[go: up one dir, main page]

ES2190941T3 - Derivados de bencilaminodiacetamidas, composiciones, composiciones que los incluyen, procedimiento de preparacion y utilizaciones. - Google Patents

Derivados de bencilaminodiacetamidas, composiciones, composiciones que los incluyen, procedimiento de preparacion y utilizaciones.

Info

Publication number
ES2190941T3
ES2190941T3 ES00400479T ES00400479T ES2190941T3 ES 2190941 T3 ES2190941 T3 ES 2190941T3 ES 00400479 T ES00400479 T ES 00400479T ES 00400479 T ES00400479 T ES 00400479T ES 2190941 T3 ES2190941 T3 ES 2190941T3
Authority
ES
Spain
Prior art keywords
compositions
derivatives
bencilaminodiacetamidas
preparation procedure
diacetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00400479T
Other languages
English (en)
Inventor
Jean-Baptiste Galey
Maria Dalko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2190941T3 publication Critical patent/ES2190941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composición que comprende, en un medio fisiológicamente aceptable, al menos un compuesto que responde a la fórmula (I) siguiente: **(Fórmula)** en la que: -R1 y R2, idénticos o diferentes están elegidos entre el hidrógeno o los radicales CH3, CF3, OCH3 y OH, -Z1 está elegido entre los radicales NX1X2 y OX1, y Z2 se elige entre los radicales NX3X4 y OX3, en los que: -X1 y X3, idénticos o diferentes, representan: -un radical alquilo de C1-C12, eventualmente substituido por uno o varios grupos OH, NH2, SH, CN, CF3, halógeno, COOH, CONHR¿, COOR¿, OR¿, SR¿ con R¿ que representa un alquilo de C1-C4; o eventualmente substituido por uno o varios ciclos de C3-C7 alifáticos o aromáticos, eventualmente heterocíclicos; o -un radical arilo, eventualmente substituido por uno o varios grupos OH, NH2, SH, CN, CF3, halógeno, COOH, CONHR¿, COOR¿, OR¿, SR¿ con R¿ que representa un alquilo de C1-C4; o eventualmente substituido por uno o varios ciclos de C3-C7 alifáticos o aromáticos, eventualmente heterocíclicos; y -X2 y X4, idénticos o diferentes, representan un átomo de hidrógeno o forman un ciclo con 5 ó 6 enlaces con X1 y X3 respectivamente.
ES00400479T 1999-03-11 2000-02-22 Derivados de bencilaminodiacetamidas, composiciones, composiciones que los incluyen, procedimiento de preparacion y utilizaciones. Expired - Lifetime ES2190941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903005A FR2790756B1 (fr) 1999-03-11 1999-03-11 Nouveaux composes de la famille des benzylaminodiacetamides, compositions les comprenant, procede de preparation et utilisations

Publications (1)

Publication Number Publication Date
ES2190941T3 true ES2190941T3 (es) 2003-09-01

Family

ID=9543058

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00400479T Expired - Lifetime ES2190941T3 (es) 1999-03-11 2000-02-22 Derivados de bencilaminodiacetamidas, composiciones, composiciones que los incluyen, procedimiento de preparacion y utilizaciones.

Country Status (8)

Country Link
US (1) US6291478B1 (es)
EP (1) EP1035110B1 (es)
JP (1) JP3715170B2 (es)
AT (1) ATE231120T1 (es)
CA (1) CA2300603C (es)
DE (1) DE60001186T2 (es)
ES (1) ES2190941T3 (es)
FR (1) FR2790756B1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077593A1 (en) * 2002-10-21 2004-04-22 Marron Susan M. Numbing gel for hair removal
US8415479B2 (en) 2008-03-31 2013-04-09 Renascience Co., Ltd. Inhibitor of plasminogen activator inhibitor-1
EP2607348B8 (en) 2009-03-31 2021-04-21 Renascience Inc. Plasminogen Activator Inhibitor-1 Inhibitor
WO2014171464A1 (ja) 2013-04-15 2014-10-23 株式会社レナサイエンス Ｐａｉ－１阻害剤の新規用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2746647B1 (fr) 1996-03-27 1998-05-15 Oreal Composition apaisante comprenant un extrait d'iridacee
FR2751538B1 (fr) * 1996-07-26 1998-09-11 Oreal Utilisation de derives de l'acide n,n'-dibenzyl ethylenediamine n,n'-diacetique comme agents depigmentants
DE19710612A1 (de) * 1997-03-14 1998-09-17 Haarmann & Reimer Gmbh N-Acyl-hydroxyaminosäureester und ihre Verwendung
JP3906514B2 (ja) * 1997-04-03 2007-04-18 味の素株式会社 アミノ酸誘導体及び抗活性酸素剤

Also Published As

Publication number Publication date
JP3715170B2 (ja) 2005-11-09
DE60001186D1 (de) 2003-02-20
CA2300603A1 (fr) 2000-09-11
JP2000290252A (ja) 2000-10-17
US6291478B1 (en) 2001-09-18
DE60001186T2 (de) 2003-10-09
EP1035110B1 (fr) 2003-01-15
EP1035110A1 (fr) 2000-09-13
FR2790756A1 (fr) 2000-09-15
ATE231120T1 (de) 2003-02-15
CA2300603C (fr) 2006-10-24
FR2790756B1 (fr) 2001-04-13

Similar Documents

Publication Publication Date Title
IS1360B6 (is) Ný tegund af lyfjablöndu
EP0614661A3 (en) Benzylidene and cinnamylidene malononitrile derivatives to inhibit proliferative processes in mammalian cells.
IL101483A0 (en) Benzimidazole derivatives,their preparation and pharmaceutical compositions containing them
IL71201A (en) Bactericidal compositions for plant protection containing quinolonecarboxylic acid derivatives and certain such novel compounds
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
HUT42440A (en) Process for preparing novel indole-carboxamide derivatives and pharmaceutical compositions comprising such compounds
ES2190941T3 (es) Derivados de bencilaminodiacetamidas, composiciones, composiciones que los incluyen, procedimiento de preparacion y utilizaciones.
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ES2118343T3 (es) Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES8103077A1 (es) Procedimiento de preparacion de nuevos derivados fenotiazi- nos o de sus sales de adicion acidas
NO885224L (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinylderivater.
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
NZ210939A (en) Oxysalicylamide derivatives and pharmaceutical compositions
FI953246A7 (fi) Välituotteet kinoliini-3-karboksyylihappojohdannaisten valmistamiseksi
SE8803932D0 (sv) New octahydro indenofuran derivatives, their preparation and therapeutic composition containing the same